Glioma - Mortality
Research News and Information

Saturday, November 21, 2009

Analysis of IDH1 and IDH2 mutations in Japanese glioma patients.

29 Sep 2009 A recent study reported on mutations in the active site of the isocitrate dehydrogenase 1 (IDH1) gene in several types of gliomas. All mutations detected resulted in an amino acid exchange at position 132. We analyzed the genomic region spanning ... Read more...

Survival and functional outcome of childhood spinal cord low-grade gliomas. Clinical article.

30 Aug 2009 OBJECT: Intramedullary spinal cord low-grade gliomas (LGGs) are rare CNS neoplasms in pediatric patients, and there is little information on therapy for and outcome of these tumors in this population. Furthermore, most patient series combine adult ... Read more...

Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic.

30 Aug 2009 BACKGROUND: Low-grade gliomas (LGGs) are uncommon in older patients, and long-term clinical behavior and prognostic factors are not well defined in this group. METHODS: The authors retrospectively searched their tumor registry for the records of ... Read more...

Latest indexed articles for 'Glioma - Mortality'

These are the very latest articles for this heading:

• Comment on "Hypericin uptake: a prognostic marker for survival in high-grade glioma". 29 Sep 2009
• Analysis of IDH1 and IDH2 mutations in Japanese glioma patients. 29 Sep 2009
• Survival and functional outcome of childhood spinal cord low-grade gliomas. Clinical article. 30 Aug 2009
• Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic. 30 Aug 2009
• Medical, psychological, cognitive and educational late-effects in pediatric low-grade glioma survivors treated with surgery only. 30 Aug 2009
• [Proton beam therapy in pediatric radiotherapy] 16 Aug 2009
• Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. 30 Jul 2009
• Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. 25 Jul 2009
• A network model of a cooperative genetic landscape in brain tumors. 13 Jul 2009
• Phase II trial of conformal radiation therapy for pediatric low-grade glioma. 4 Jul 2009
• Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. 4 Jul 2009
• Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma. 29 Jun 2009
• Serial stereotactic biopsy of brainstem lesions in adults improves diagnostic accuracy compared with MRI only. 8 Jun 2009
• Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: analysis of the response and core pathway aberrations. 3 Jun 2009
• Radiotherapy management of patients diagnosed with glioma in Victoria (1998-2000): a retrospective cohort study. 30 May 2009
• Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model. 30 May 2009
• Efficacy of anti-epileptic drugs in patients with gliomas and seizures. 10 May 2009
• Surgical considerations for 'intrinsic' brainstem gliomas: proposal of a modification in classification. 29 Apr 2009
• The parametric response map is an imaging biomarker for early cancer treatment outcome. 17 Apr 2009
• Brainstem gliomas--retrospective analysis of 86 patients. Apr 2009

See a longer list of these articles.

Technical information about 'Glioma'

Definition: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Descriptor UI: D005910

Alternative terms: Glioma; Gliomas; Glial Cell Tumors; Glial Cell Tumor; Tumor, Glial Cell; Tumors, Glial Cell; Mixed Glioma; Glioma, Mixed; Gliomas, Mixed; Mixed Gliomas; Malignant Glioma; Glioma, Malignant; Gliomas, Malignant; Malignant Gliomas;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.557.465.625.600.380; C04.557.470.670.380; C04.557.580.625.600.380;

Technical Notes: coord IM with precoord CNS/neopl term + site (IM); GLIOMA, SUBEPENDYMAL is available; for sarcomatous GLIOMA use GLIOSARCOMA; for GLIOMA, RETINAL see RETINOBLASTOMA